149 related articles for article (PubMed ID: 36000493)
1. Silencing of OGDHL promotes liver cancer metastasis by enhancing hypoxia inducible factor 1 α protein stability.
Dai W; Li Y; Sun W; Ji M; Bao R; Chen J; Xu S; Dai Y; Chen Y; Liu W; Ge C; Sun W; Mo W; Guo C; Xu X
Cancer Sci; 2023 Apr; 114(4):1309-1323. PubMed ID: 36000493
[TBL] [Abstract][Full Text] [Related]
2. PROX1 promotes hepatocellular carcinoma metastasis by way of up-regulating hypoxia-inducible factor 1α expression and protein stability.
Liu Y; Zhang JB; Qin Y; Wang W; Wei L; Teng Y; Guo L; Zhang B; Lin Z; Liu J; Ren ZG; Ye QH; Xie Y
Hepatology; 2013 Aug; 58(2):692-705. PubMed ID: 23505027
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia upregulates Rab11-family interacting protein 4 through HIF-1α to promote the metastasis of hepatocellular carcinoma.
Hu F; Deng X; Yang X; Jin H; Gu D; Lv X; Wang C; Zhang Y; Huo X; Shen Q; Luo Q; Zhao F; Ge T; Zhao F; Chu W; Shu H; Yao M; Fan J; Qin W
Oncogene; 2015 Dec; 34(49):6007-17. PubMed ID: 25745995
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.
Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C
BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980
[TBL] [Abstract][Full Text] [Related]
5. Regulation of COX-2 expression and epithelial-to-mesenchymal transition by hypoxia-inducible factor-1α is associated with poor prognosis in hepatocellular carcinoma patients post TACE surgery.
Huang M; Wang L; Chen J; Bai M; Zhou C; Liu S; Lin Q
Int J Oncol; 2016 May; 48(5):2144-54. PubMed ID: 26984380
[TBL] [Abstract][Full Text] [Related]
6. HIF-1α promoted vasculogenic mimicry formation in hepatocellular carcinoma through LOXL2 up-regulation in hypoxic tumor microenvironment.
Wang M; Zhao X; Zhu D; Liu T; Liang X; Liu F; Zhang Y; Dong X; Sun B
J Exp Clin Cancer Res; 2017 Apr; 36(1):60. PubMed ID: 28449718
[TBL] [Abstract][Full Text] [Related]
7. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
[TBL] [Abstract][Full Text] [Related]
8. HIF-1α plays a role in the chemotactic migration of hepatocarcinoma cells through the modulation of CXCL6 expression.
Tian H; Huang P; Zhao Z; Tang W; Xia J
Cell Physiol Biochem; 2014; 34(5):1536-46. PubMed ID: 25323032
[TBL] [Abstract][Full Text] [Related]
9. ELK3 promotes the migration and invasion of liver cancer stem cells by targeting HIF-1α.
Lee JH; Hur W; Hong SW; Kim JH; Kim SM; Lee EB; Yoon SK
Oncol Rep; 2017 Feb; 37(2):813-822. PubMed ID: 27959451
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia promotes the migration and invasion of human hepatocarcinoma cells through the HIF-1α-IL-8-Akt axis.
Fei M; Guan J; Xue T; Qin L; Tang C; Cui G; Wang Y; Gong H; Feng W
Cell Mol Biol Lett; 2018; 23():46. PubMed ID: 30258464
[TBL] [Abstract][Full Text] [Related]
11. HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression.
Zeng Z; Shi Z; Liu Y; Zhao J; Lu Q; Guo J; Liu X; Huang D; Xu Q
Biochem Biophys Res Commun; 2021 Aug; 566():80-86. PubMed ID: 34118595
[TBL] [Abstract][Full Text] [Related]
12. The role of Aurora A in hypoxia-inducible factor 1α-promoting malignant phenotypes of hepatocelluar carcinoma.
Cui SY; Huang JY; Chen YT; Song HZ; Huang GC; De W; Wang R; Chen LB
Cell Cycle; 2013 Sep; 12(17):2849-66. PubMed ID: 23966163
[TBL] [Abstract][Full Text] [Related]
13. Lysyl oxidase induces epithelial-mesenchymal transition and predicts intrahepatic metastasis of hepatocellular carcinoma.
Umezaki N; Nakagawa S; Yamashita YI; Kitano Y; Arima K; Miyata T; Hiyoshi Y; Okabe H; Nitta H; Hayashi H; Imai K; Chikamoto A; Baba H
Cancer Sci; 2019 Jun; 110(6):2033-2043. PubMed ID: 30919528
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca
Dou C; Zhou Z; Xu Q; Liu Z; Zeng Y; Wang Y; Li Q; Wang L; Yang W; Liu Q; Tu K
Oncogene; 2019 Feb; 38(8):1239-1255. PubMed ID: 30250300
[TBL] [Abstract][Full Text] [Related]
15. NAD(P)HX epimerase downregulation promotes tumor progression through ROS/HIF-1α signaling in hepatocellular carcinoma.
Sun B; Yu L; Xu C; Li YM; Zhao YR; Cao MM; Yang LY
Cancer Sci; 2021 Jul; 112(7):2753-2769. PubMed ID: 33932069
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma.
Liu Z; Wang Y; Dou C; Xu M; Sun L; Wang L; Yao B; Li Q; Yang W; Tu K; Liu Q
Theranostics; 2018; 8(17):4649-4663. PubMed ID: 30279729
[No Abstract] [Full Text] [Related]
17. 14-3-3ζ promotes hepatocellular carcinoma venous metastasis by modulating hypoxia-inducible factor-1α.
Tang Y; Liu S; Li N; Guo W; Shi J; Yu H; Zhang L; Wang K; Liu S; Cheng S
Oncotarget; 2016 Mar; 7(13):15854-67. PubMed ID: 26910835
[TBL] [Abstract][Full Text] [Related]
18. Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition.
Feng B; Zhu Y; Sun C; Su Z; Tang L; Li C; Zheng G
Int J Biol Macromol; 2019 Sep; 137():32-44. PubMed ID: 31252022
[TBL] [Abstract][Full Text] [Related]
19. HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway.
Chen T; Liu R; Niu Y; Mo H; Wang H; Lu Y; Wang L; Sun L; Wang Y; Tu K; Liu Q
Cell Death Dis; 2021 Dec; 12(12):1152. PubMed ID: 34903711
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA PAARH promotes hepatocellular carcinoma progression and angiogenesis via upregulating HOTTIP and activating HIF-1α/VEGF signaling.
Wei H; Xu Z; Chen L; Wei Q; Huang Z; Liu G; Li W; Wang J; Tang Q; Pu J
Cell Death Dis; 2022 Feb; 13(2):102. PubMed ID: 35110549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]